Hansoh Pharmaceutical Group Company Limited (3KY.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
At close: 09:15AM CET
| Previous Close | 1.5900 |
| Open | 1.5900 |
| Bid | 1.5900 x N/A |
| Ask | 1.7300 x N/A |
| Day's Range | 1.5900 - 1.5900 |
| 52 Week Range | 1.4000 - 2.1600 |
| Volume | |
| Avg. Volume | 32 |
| Market Cap | 10.25B |
| Beta (5Y Monthly) | 0.59 |
| PE Ratio (TTM) | 28.39 |
| EPS (TTM) | 0.0560 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.02 (1.00%) |
| Ex-Dividend Date | Sept 08, 2022 |
| 1y Target Est | N/A |
- Business Wire
KiOmed Pharma and Hansoh Pharma Announce License Agreement for KiOmedinevsOne in China’s Mainland, Macau and Taiwan
HERSTAL, Belgium & SHANGHAI, September 26, 2022--KiOmed Pharma, a Belgian biotechnology company with a focus on the development, manufacture and distribution of safe and effective medical devices based on a medical-grade highly pure natural chitosan-derivative, and Hansoh Pharmaceutical Group Company Limited (SEHK: 3692), a leading biopharmaceutical company in Asia, today announced a license agreement for the development and commercialization of KiOmedinevsOne, a carboxymethyl chitosan injection
© 2023 Yahoo. All rights reserved.
